HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,934	23,709	45,821	99,873	13,930
Short-Term Investments	9,567	8,644	18,101	560	14,601
Trading Asset Securities	10,272	-	89.45	134.25	254.64
Cash & Short-Term Investments	37,773	32,353	64,012	100,567	28,786
Cash Growth	16.75%	-49.46%	-36.35%	249.37%	-40.21%
Accounts Receivable	8,626	9,497	7,900	6,448	4,391
Other Receivables	165.82	339.49	625.47	1,442	170.86
Receivables	8,792	9,837	8,527	8,874	5,617
Inventory	5,373	5,336	6,455	2,345	3,236
Prepaid Expenses	274.38	161.96	151.72	133.07	4.45
Other Current Assets	1,913	2,138	865.59	1,333	216
Total Current Assets	54,125	49,825	80,012	113,253	37,859
Property, Plant & Equipment	9,530	10,068	15,780	9,781	9,162
Long-Term Investments	61,804	58,608	20,335	3,715	15,382
Goodwill	5,388	5,388	1,075	382.08	4,826
Other Intangible Assets	5,399	4,896	4,260	3,925	3,918
Long-Term Deferred Charges	78,283	69,100	63,472	57,586	50,418
Other Long-Term Assets	5,264	2,910	2,709	1,070	372.3
Total Assets	219,793	200,795	187,643	189,711	121,938
Accounts Payable	4,817	8,183	2,517	1,272	2,877
Accrued Expenses	1,106	902.2	1,510	1,819	814.93
Short-Term Debt	17,531	7,436	51,551	50,441	12,949
Current Portion of Long-Term Debt	-	-	98	-	-
Current Portion of Leases	450.97	624.24	297.68	364.54	166.25
Other Current Liabilities	8,000	9,645	2,655	2,820	1,527
Total Current Liabilities	31,904	26,791	58,628	56,717	18,335
Long-Term Debt	5,170	1,840	48	-	-
Long-Term Leases	200.58	122.2	136.74	320.7	218.7
Other Long-Term Liabilities	194.81	194.81	194.81	194.81	194.81
Total Liabilities	37,925	29,276	59,528	59,672	21,632
Common Stock	40,070	37,016	15,992	15,668	13,475
Additional Paid-In Capital	136,440	125,176	97,290	190,850	145,207
Retained Earnings	-30,176	-4,862	-1,916	-90,644	-73,451
Treasury Stock	-1,120	-483.65	-413.53	-413.53	-413.53
Comprehensive Income & Other	12,250	3,620	5,754	3,219	4,535
Total Common Equity	157,465	160,466	116,708	118,679	89,354
Minority Interest	24,404	11,053	11,408	11,360	10,952
Shareholders' Equity	181,868	171,519	128,116	130,039	100,306
Total Liabilities & Equity	219,793	200,795	187,643	189,711	121,938
Total Debt	23,353	10,022	52,131	51,126	13,334
Net Cash (Debt)	14,420	22,330	11,881	49,441	15,451
Net Cash Growth	-35.42%	87.95%	-75.97%	219.98%	-
Net Cash Per Share	174.09	286.72	174.61	805.53	270.01
Filing Date Shares Outstanding	83.74	77.39	34.42	69.79	59.93
Total Common Shares Outstanding	83.74	77.39	68.85	69.79	59.93
Working Capital	22,221	23,034	21,384	56,536	19,524
Book Value Per Share	1880.38	2073.35	1695.21	1700.41	1490.96
Tangible Book Value	146,678	150,182	111,372	114,372	80,609
Tangible Book Value Per Share	1751.57	1940.48	1617.72	1638.70	1345.05
Land	4,429	4,429	5,916	4,429	4,429
Buildings	5,150	5,150	8,467	5,146	5,146
Machinery	2,838	2,927	10,253	2,737	2,396
Construction In Progress	-	-	263.3	-	-

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.